FDA Issues Form 483 to Jubilant HollisterStier
29 Oct 2024 //
FDA
USFDA Inspection Update On Jubilant HollisterStier’s Facility
01 Oct 2024 //
INDPHARMAPOST
Jubilant HollisterStier Announces New President
16 Mar 2023 //
BUSINESSWIRE
Jubilant HollisterStier Appoints Chris Preti President
16 Mar 2023 //
CONTRACT PHARMA
Jubilant HollisterStier Expands Capabilities at Montreal Manufacturing Facility
12 Jul 2022 //
CONTRACTPHARMA
Jubilant HollisterStier enters into $149.6M cooperative agreement with US Govt.
30 May 2022 //
PRNEWSWIRE
Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
15 Jun 2021 //
CONTRACTPHARMA
Ocugen and Jubilant Enter COVID-19 Vaccine Partnership
15 Jun 2021 //
CONTRACTPHARMA
Jubilant HollisterStier plots out expansion at WA sterile injectables plant
10 Jun 2021 //
ENDPTS
Jubilant, Novavax Enter COVID-19 Vaccine Partnership
29 Mar 2021 //
CONTRACTPHARMA
Jubilant HollisterStier, Eli Lilly Enter COVID-19 Treatment Collaboration
09 Mar 2021 //
PRESS RELEASE
Jubilant HollisterStier Contract Manufacturing & Services
27 Feb 2019 //
CONTRACT PHARMA